INS and type 2 diabetes mellitus: Emerging evidence has demonstrated the key role of phosphatidylethanolamine in the insulin signaling pathway, and it was suggested that increased phosphatidylcholine/phosphatidylethanolamines ratio was associated with reduced insulin sensitivity [27] and elevated among patients with type 2 diabetes [28].